Genotype Triad for
HOTAIR
LINC-ROR
MALAT1
SLE
long non-coding RNAs
lupus nephritis
single nucleotide polymorphism
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
11 May 2022
11 May 2022
Historique:
received:
16
04
2022
revised:
04
05
2022
accepted:
06
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Accumulating evidence supports the implication of long non-coding RNAs (lncRNAs) in autoimmune diseases, including systemic lupus erythematosus (SLE). LncRNA variants could impact the development and/or outcome of the disease with variable diagnostic/prognostic utility in the clinic. We aimed to explore the contribution of HOTAIR (rs10783618), LINC-ROR (rs1942347), and MALAT1 (rs3200401) variants to SLE susceptibility and/or severity in 163 SLE patients and age-/sex-matched controls using real-time TaqMan allelic discrimination PCR. HOTAIR rs10783618*C/C was associated with a 77% increased risk of SLE (OR = 1.77, 95%CI = 1.09−2.87, p = 0.020) under the recessive model. Similarly, MALAT1 rs3200401*T/T carriers were three times more likely to develop SLE (OR = 2.89, 95%CI = 1.42−5.90) under the recessive model. While the rs3200401*T/C genotype was associated with a 49−57% decreased risk of SLE under codominant (OR = 0.51, 95%CI = 0.31−0.82, p < 0.001) and over-dominant (OR = 0.43, 95%CI = 0.27−0.68, p < 0.001) models. LINC-ROR rs1942347*A/A patients were more likely to have a positive family history of SLE. At the same time, HOTAIR rs10783618*C/C was associated with a higher frequency of arthritis (p = 0.001) and the presence of oral ulcers (p = 0.002), while patients carrying rs10783618*T/T genotype were more likely to develop hair loss (p < 0.001), weight loss (p = 0.001), and neurological symptoms (p = 0.003). In conclusion, the studied lncRNAs, HOTAIR, and MALAT1 gene polymorphisms confer susceptibility for SLE, providing a potential theoretical basis for their clinical translation in SLE disease.
Identifiants
pubmed: 35626352
pii: diagnostics12051197
doi: 10.3390/diagnostics12051197
pmc: PMC9139987
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
IUBMB Life. 2019 Sep;71(9):1367-1381
pubmed: 31188529
Biomed Res Int. 2013;2013:251098
pubmed: 23862139
Curr Opin Rheumatol. 2014 Sep;26(5):482-92
pubmed: 25010439
Biomolecules. 2020 Dec 06;10(12):
pubmed: 33291347
Arthritis Rheumatol. 2020 Jun;72(6):985-996
pubmed: 31930717
Biochem Soc Trans. 2012 Aug;40(4):902-6
pubmed: 22817756
Nephrology (Carlton). 2019 Apr;24(4):472-480
pubmed: 29717517
Yonsei Med J. 2019 Nov;60(11):1081-1092
pubmed: 31637891
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462
Clin Rev Allergy Immunol. 2016 Jun;50(3):333-44
pubmed: 26969025
Bioinformatics. 2006 Aug 1;22(15):1928-9
pubmed: 16720584
Biomed Pharmacother. 2018 Oct;106:584-592
pubmed: 29990846
Anticancer Res. 2014 Nov;34(11):6669-76
pubmed: 25368273
Am J Cancer Res. 2015 Feb 15;5(3):907-27
pubmed: 26045977
Cell Cycle. 2021 Feb;20(3):332-344
pubmed: 33467979
J Autoimmun. 2016 Dec;75:96-104
pubmed: 27481557
Biomed Res Int. 2016;2016:8631061
pubmed: 27429984
PLoS One. 2016 Apr 04;11(4):e0152834
pubmed: 27043015
Mol Immunol. 2019 Aug;112:22-29
pubmed: 31075559
Cancers (Basel). 2020 Nov 15;12(11):
pubmed: 33203119
J Rheumatol. 2006 Aug;33(8):1563-9
pubmed: 16881113
Orphanet J Rare Dis. 2013 Jan 07;8:2
pubmed: 23289717
Nat Rev Rheumatol. 2020 Mar;16(3):126
pubmed: 32005955
Annu Rev Immunol. 2017 Apr 26;35:177-198
pubmed: 28125358
Semin Nephrol. 2010 Mar;30(2):164-76
pubmed: 20347645
J Cell Physiol. 2017 Dec;232(12):3422-3432
pubmed: 28067428
Arthritis Rheum. 1992 Jun;35(6):630-40
pubmed: 1599520
Biomolecules. 2020 Jun 22;10(6):
pubmed: 32580306
Oncotarget. 2017 Aug 24;8(44):77400-77406
pubmed: 29100395
Autoimmun Rev. 2019 Apr;18(4):382-392
pubmed: 30772495
J Biomed Mater Res A. 2019 Feb;107(2):468-475
pubmed: 30478988
Anticancer Res. 2012 Apr;32(4):1119-36
pubmed: 22493341
Cell Death Dis. 2018 Jun 15;9(7):711
pubmed: 29907764
Clin Exp Immunol. 2017 Mar;187(3):327-336
pubmed: 27880973
FASEB J. 2020 May;34(5):6070-6085
pubmed: 32246794
Wound Repair Regen. 2021 May;29(3):495-504
pubmed: 33721916
Arthritis Care Res (Hoboken). 2014 Apr;66(4):608-16
pubmed: 24106157
Cell Biosci. 2017 Apr 21;7:19
pubmed: 28439401
Braz J Med Biol Res. 2020 Apr 17;53(5):e9292
pubmed: 32321151
Curr Rheumatol Rep. 2019 Jan 23;21(1):3
pubmed: 30673885
Clin Exp Med. 2015 Feb;15(1):121-6
pubmed: 24722995
Front Med (Lausanne). 2018 Jul 03;5:193
pubmed: 30018955
J Clin Med. 2021 Oct 30;10(21):
pubmed: 34768615
Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188316
pubmed: 31639408
BMC Mol Cell Biol. 2020 Jul 10;21(1):53
pubmed: 32650720
Cytokine. 2021 Feb;138:155397
pubmed: 33341002
J Mol Neurosci. 2020 Oct;70(10):1533-1540
pubmed: 32578033
Cells. 2019 Sep 30;8(10):
pubmed: 31575058
Rheum Dis Clin North Am. 2014 Aug;40(3):401-12, vii
pubmed: 25034153
Diagnostics (Basel). 2021 Jul 26;11(8):
pubmed: 34441278
Melanoma Res. 2014 Aug;24(4):335-41
pubmed: 24892958
Lupus. 2021 Oct;30(12):1923-1930
pubmed: 34482739
Epigenetics. 2014 Jan;9(1):21-6
pubmed: 24335342
Int J Mol Sci. 2019 Nov 09;20(22):
pubmed: 31717552
Arthritis Res Ther. 2020 Dec 10;22(1):286
pubmed: 33303026
Tumour Biol. 2015 Apr;36(4):2845-54
pubmed: 25476857
Front Immunol. 2018 Dec 18;9:2967
pubmed: 30619325
Int Immunopharmacol. 2021 Sep;98:107903
pubmed: 34192661